Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Prophase Labs Inc
(NQ:
PRPH
)
5.260
-0.180 (-3.31%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
99,267
Open
5.310
Bid (Size)
5.100 (1)
Ask (Size)
6.100 (1)
Prev. Close
5.440
Today's Range
5.050 - 5.310
52wk Range
4.050 - 9.400
Shares Outstanding
16,277,764
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
PRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q4 2023
March 15, 2024
PRPH stock results show that ProPhase Labs missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For March 15, 2024
March 15, 2024
Companies Reporting Before The Bell • EHang Holdings (NASDAQ:EH) is expected to report quarterly loss at $0.10 per share on revenue of $7.83 million.
Via
Benzinga
Performance
YTD
+13.36%
+13.36%
1 Month
-4.88%
-4.88%
3 Month
+6.26%
+6.26%
6 Month
+15.60%
+15.60%
1 Year
-30.88%
-30.88%
More News
Read More
ProPhase Labs's Earnings: A Preview
March 14, 2024
Via
Benzinga
ProPhase Labs Earnings Preview
November 08, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 29, 2023
Via
Benzinga
Analyst Expectations for ProPhase Labs's Future
May 12, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 11, 2023
Via
Benzinga
DSS, Inc.'s (NYSE American: DSS) Subsidiary Appoints New Chief Investment Officer To Aggressively Develop Mutual Fund Business For Eventual Spinoff
July 26, 2023
Via
Benzinga
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
June 27, 2023
Via
News Direct
Recap: ProPhase Labs Q1 Earnings
May 11, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
April 10, 2023
Via
Benzinga
ProPhase Labs Earnings Preview
March 27, 2023
Via
Benzinga
Earnings Scheduled For August 10, 2023
August 10, 2023
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
January 23, 2023
Via
Benzinga
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
June 27, 2023
Via
TheNewswire.com
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
June 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
June 01, 2023
Via
Benzinga
7 Small-Cap Biotech Stocks with Massive Potential
April 27, 2023
Via
InvestorPlace
Impact Biomedical Preparing A Potential Spinoff — What Does This Mean For Investors Of Holding Company DSS, Inc (NYSE American: DSS)?
March 27, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
January 09, 2023
Via
Benzinga
ProPhase Labs's Return On Capital Employed Overview
December 20, 2022
Via
Benzinga
5 Value Stocks In The Healthcare Sector
December 05, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 11, 2023
Via
Benzinga
ProPhase Labs to Present at the Planet MicroCap Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022
November 30, 2022
From
ProPhase Labs, Inc.
Via
GlobeNewswire
ProPhase Labs Announces Record Third Quarter 2022 Financial Results
November 10, 2022
From
ProPhase Labs, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.